• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 30525
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Congestive Heart Failure (1783); Unspecified Infection (1930); Myocardial Infarction (1969); Ventricular Fibrillation (2130); Complete Heart Block (2627)
Event Date 09/03/2015
Event Type  Injury  
Manufacturer Narrative
Citation: y.Okamoto, "early and late outcomes of aortic valve replacement with aortic annular enlargement: a propensity analysis" thorac cardiovasc surg 2016;64:410¿417.Doi http://dx.Doi.Org/10.1055/s-0035-1563669.Issn 0171-6425.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.(b)(4).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding early and late outcomes of aortic valve replacement with aortic annular enlargement: a propensity analysis.All data were collected from a single center between january 2001 and july 2014.The study population included 589 patients (predominantly female, mean age 73 years), 51 of which were implanted with medtronic mosaic (serial numbers not provided).Among all patients 11 deaths occurred.Based on the available information, none of the deaths were attributed to medtronic product.Among all patients adverse events included: complete heart block, low output syndrome, perioperative mi, stroke, ventricular fibrillation, sepsis, chest infection, and congestive heart failure.Based on the available information, these events may have been attributed to medtronic product.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6686035
MDR Text Key79051430
Report Number2025587-2017-01090
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number30525
Device Catalogue Number30525
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/15/2017
Initial Date FDA Received07/05/2017
Supplement Dates Manufacturer Received06/15/2017
Supplement Dates FDA Received09/07/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age73 YR
-
-